Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.9M Sell
61,500
-178,200
-74% -$20.9M 0.01% 965
2026
Q1
$28.8M Buy
239,700
+7,600
+3% +$877K 0.05% 287
2025
Q4
$24.4M Sell
232,100
-559,900
-71% -$52.6M 0.05% 348
2025
Q3
$66.5M Sell
792,000
-82,700
-9% -$6.81M 0.11% 123
2025
Q2
$69.2M Buy
874,700
+249,600
+40% +$19.8M 0.15% 80
2025
Q1
$56.1M Buy
625,100
+549,200
+724% +$51.3M 0.19% 56
2024
Q4
$7.55M Buy
75,900
+48,200
+174% +$4.97M 0.03% 486
2024
Q3
$3.15M Buy
27,700
+17,400
+169% +$2.07M 0.01% 949
2024
Q2
$1.28M Buy
+10,300
New +$1.33M 0.01% 1330
2024
Q1
Sell
-60,100
Closed -$6.55M 2576
2023
Q4
$6.55M Buy
60,100
+28,600
+91% +$2.97M 0.05% 511
2023
Q3
$3.24M Buy
31,500
+12,700
+68% +$1.37M 0.03% 690
2023
Q2
$2.17M Sell
18,800
-1,300
-6% -$148K 0.03% 858
2023
Q1
$2.14M Buy
+20,100
New +$2.17M 0.03% 748
2021
Q4
Sell
-27,300
Closed -$2.05M 2792
2021
Q3
$2.05M Buy
+27,300
New +$2.08M 0.03% 688

Other funds holding MRK

Paul Tudor Jones's MRK Position: Q4 2025 in Review

Paul Tudor Jones sold out of Merck (MRK) in Q4 2025, closing a stake of 787,366 shares — an estimated $73.9M sold.

Paul Tudor Jones first reported a position in MRK in Q2 2013 and held it in 34 quarters. The position peaked at $69.5M in Q1 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Paul Tudor Jones reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 787,366 Merck shares in Q4 2025, an estimated $73.9M.
  • Paul Tudor Jones first reported a position in Merck in Q2 2013 and held it in 34 quarters.
  • Paul Tudor Jones's Merck position peaked at $69.5M in Q1 2025.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.